Proven growth- and later-stage companies with demonstrated market traction can take advantage of royalty financing, also called revenue-based financing. This type of financing differs from standard debt financing. Lenders provide capital to the business in return for a percentage of ongoing revenues. However, investors do not take an upfront ownership stake in the business, leaving equity ownership unchanged. This is often an attractive and creative non-dilutive way to raise capital for tangible, asset-light, intellectual property-rich companies.
Optimal Structuring of Royalty-Based Financing
At Armentum, we are experts in structuring revenue and royalty-based financing solutions with proven transaction experience. We make sure you get the capital you need to grow your business without suffering equity dilution —in short, we find the right balance to keep you thriving.
We Raise between $10MM and $200MM.
Revenue-based Solutions for Progressive Companies
Let’s discuss how Armentum can facilitate royalty financing for your business.
JDS TherapeuticsSenior Debt $25,000,000
G1 TherapeuticsSenior Debt $150,000,000
ClearsenseSenior Debt $25,000,000
Mersana TherapeuticsSenior Debt $100,000,000
ViscogliosiNAV-based financing $70,000,000
Pi-CardiaSenior Debt $21,000,000
GetaroundSenior Debt $75,000,000
Eloxx PharmaceuticalsSenior Debt $30,000,000
Armentum Partners is an independent financial services firm focused on facilitating debt transactions primarily for technology and healthcare companies. We provide non-dilutive capital-raising solutions, including venture debt, middle market debt and royalty financings. Utilizing our deep industry knowledge, years of experience, and long-term, trusted relationships with lenders, we transform companies and facilitate continuous growth.